15, which was derived from (S)-tert-leucinol, produced (S)-18 in preference to (R)-18. A series of azolium salts were synthesized from (S)-serine esters, and the reaction conditions for the ECA reaction were optimized to produce (R)-18 with 69% ee. The best results were obtained in the case of the reaction of 4,4-dimethyl-2-cyclohexen-1-one (34) with Et2Zn catalyzed by Cu(OTf)2 in combination with azolium
Functionalized N-Heterocyclic Carbene Ligands for Dual Enantioselective Control in the Cu-Catalyzed Conjugate Addition of Dialkylzinc Compounds to Acyclic Enones
A series of highly tunable, functionalized azolium compounds have been synthesized from chiral α-amino acid derivatives such as β-amino alcohols or α-amino esters. The combination of a Cu salt and a chiral azolium efficiently facilitated the asymmetric conjugate addition (ACA) reactions of acyclic enones with dialkylzinc under ambient conditions without temperature control. Of the (hydroxy amide)-functionalized
C2-symmetric ester-amide functionalized azolium salt was synthesized from readily available α-amino ester such as L-serine methyl ester. The combination of a Cu salt and the chiral azolium salt promoted the asymmetric conjugateadditionreaction of enones with dialkylzincs. Thus, treatment of acyclic enone such as chalcone with Et2Zn afforded the corresponding 1,4-adduct with up to 85% ee. An excellent
Herein we describe compositions and methods for the synthesis of [2.2.2]-diazabicyclic structures comprising a domino reaction sequence involving aldol condensation, alkene isomerization, and intramolecular hetero-Diels-Alder cycloaddition. Excellent diastereofacial control during the cycloaddition is enforced with a removable chiral phenyl aminal diketopiperazine substituent. The reaction sequence rapidly generates molecular complexity and is competent with both enolizable and non-enolizable aldehyde substrates. This method provides an efficient route to [2.2.2]-diazabicyclic structures, common to bioactive prenylated indole alkaloids such as the brevianamides and stephacidins.